▶ 調査レポート

世界の黄斑浮腫治療薬市場：市場規模・現状・予測
• 英文タイトル：Global Macular Edema Therapeutics Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の黄斑浮腫治療薬市場：市場規模・現状・予測 / Global Macular Edema Therapeutics Market Size, Status and Forecast 2019-2025 / QYR9N7495資料のイメージです。• レポートコード：QYR9N7495
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、黄斑浮腫治療薬のグローバル市場について調査・分析したレポートで、種類別（レーザー治療、抗VEGF注射、抗炎症治療、硝子体手術）、用途別（嚢胞状黄斑浮腫（CME）、糖尿病性黄斑浮腫（DME））、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・黄斑浮腫治療薬の世界市場規模
・主要企業別市場シェア
・黄斑浮腫治療薬の世界市場規模：種類別（レーザー治療、抗VEGF注射、抗炎症治療、硝子体手術）
・黄斑浮腫治療薬の世界市場規模：用途別（嚢胞状黄斑浮腫（CME）、糖尿病性黄斑浮腫（DME））
・黄斑浮腫治療薬のアメリカ市場規模（種類別、用途別）
・黄斑浮腫治療薬のヨーロッパ市場規模（種類別、用途別）
・黄斑浮腫治療薬の中国市場規模（種類別、用途別）
・黄斑浮腫治療薬の日本市場規模（種類別、用途別）
・黄斑浮腫治療薬の東南アジア市場規模（種類別、用途別）
・黄斑浮腫治療薬のインド市場規模（種類別、用途別）
・黄斑浮腫治療薬の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・黄斑浮腫治療薬の世界市場予測（2019年-2025年）
・黄斑浮腫治療薬の地域別市場予測（2019年-2025年）
...

Macula is oval yellowish area surrounding the center of retina in the eye. Macular edema is the state when fluid and protein start accumulating under macula resulting swelling in the eye. Due to this swelling, central vision of eye get distorted. Macular edema is classified into two types namely cystoids macular edema (CME) and diabetic macular edema (DME).The market of macular edema is dominated by North America which is followed by Europe due tremendous number of population suffering from diabetics. Asia Pacific region have also shown faster rate of increases of macular edema therapeutics market. While Africa and Australia have low market of Macular edema. In Asia pacific region India, China and Brazil have shown emerging growth in the global market of macular edema therapeutics.
In 2018, the global Macular Edema Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Macular Edema Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Macular Edema Therapeutics development in United States, Europe and China.

The key players covered in this study
Allergan
Novartis
Roche
Regeneron Pharmaceuticals
Pfizer
Bayer
Boehringer Ingelheim
Bausch & Lomb
Aciont
ActiveSite Pharmaceuticals
Adverum Biotechnologies
Aerpio Therapeutics
Ampio Pharmaceuticals
Araim Pharmaceuticals
Astellas Pharma

Market segment by Type, the product can be split into
Laser Treatment
Anti-VEGF Injection
Anti-Inflammatory Treatment
Vitrectomy

Market segment by Application, split into
Cystoid Macular Edema (CME)
Diabetic Macular Edema(DME)

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Macular Edema Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Macular Edema Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Macular Edema Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Macular Edema Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Laser Treatment
1.4.3 Anti-VEGF Injection
1.4.4 Anti-Inflammatory Treatment
1.4.5 Vitrectomy
1.5 Market by Application
1.5.1 Global Macular Edema Therapeutics Market Share by Application (2014-2025)
1.5.2 Cystoid Macular Edema (CME)
1.5.3 Diabetic Macular Edema(DME)
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Macular Edema Therapeutics Market Size
2.2 Macular Edema Therapeutics Growth Trends by Regions
2.2.1 Macular Edema Therapeutics Market Size by Regions (2014-2025)
2.2.2 Macular Edema Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Macular Edema Therapeutics Market Size by Manufacturers
3.1.1 Global Macular Edema Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Macular Edema Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Macular Edema Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Macular Edema Therapeutics Key Players Head office and Area Served
3.3 Key Players Macular Edema Therapeutics Product/Solution/Service
3.4 Date of Enter into Macular Edema Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Macular Edema Therapeutics Market Size by Type (2014-2019)
4.2 Global Macular Edema Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Macular Edema Therapeutics Market Size (2014-2019)
5.2 Macular Edema Therapeutics Key Players in United States
5.3 United States Macular Edema Therapeutics Market Size by Type
5.4 United States Macular Edema Therapeutics Market Size by Application

6 Europe
6.1 Europe Macular Edema Therapeutics Market Size (2014-2019)
6.2 Macular Edema Therapeutics Key Players in Europe
6.3 Europe Macular Edema Therapeutics Market Size by Type
6.4 Europe Macular Edema Therapeutics Market Size by Application

7 China
7.1 China Macular Edema Therapeutics Market Size (2014-2019)
7.2 Macular Edema Therapeutics Key Players in China
7.3 China Macular Edema Therapeutics Market Size by Type
7.4 China Macular Edema Therapeutics Market Size by Application

8 Japan
8.1 Japan Macular Edema Therapeutics Market Size (2014-2019)
8.2 Macular Edema Therapeutics Key Players in Japan
8.3 Japan Macular Edema Therapeutics Market Size by Type
8.4 Japan Macular Edema Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Macular Edema Therapeutics Market Size (2014-2019)
9.2 Macular Edema Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Macular Edema Therapeutics Market Size by Type
9.4 Southeast Asia Macular Edema Therapeutics Market Size by Application

10 India
10.1 India Macular Edema Therapeutics Market Size (2014-2019)
10.2 Macular Edema Therapeutics Key Players in India
10.3 India Macular Edema Therapeutics Market Size by Type
10.4 India Macular Edema Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Macular Edema Therapeutics Market Size (2014-2019)
11.2 Macular Edema Therapeutics Key Players in Central & South America
11.3 Central & South America Macular Edema Therapeutics Market Size by Type
11.4 Central & South America Macular Edema Therapeutics Market Size by Application

12 International Players Profiles
12.1 Allergan
12.1.1 Allergan Company Details
12.1.2 Company Description and Business Overview
12.1.3 Macular Edema Therapeutics Introduction
12.1.4 Allergan Revenue in Macular Edema Therapeutics Business (2014-2019)
12.1.5 Allergan Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Macular Edema Therapeutics Introduction
12.2.4 Novartis Revenue in Macular Edema Therapeutics Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Roche
12.3.1 Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Macular Edema Therapeutics Introduction
12.3.4 Roche Revenue in Macular Edema Therapeutics Business (2014-2019)
12.3.5 Roche Recent Development
12.4 Regeneron Pharmaceuticals
12.4.1 Regeneron Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Macular Edema Therapeutics Introduction
12.4.4 Regeneron Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2014-2019)
12.4.5 Regeneron Pharmaceuticals Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Macular Edema Therapeutics Introduction
12.5.4 Pfizer Revenue in Macular Edema Therapeutics Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 Bayer
12.6.1 Bayer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Macular Edema Therapeutics Introduction
12.6.4 Bayer Revenue in Macular Edema Therapeutics Business (2014-2019)
12.6.5 Bayer Recent Development
12.7 Boehringer Ingelheim
12.7.1 Boehringer Ingelheim Company Details
12.7.2 Company Description and Business Overview
12.7.3 Macular Edema Therapeutics Introduction
12.7.4 Boehringer Ingelheim Revenue in Macular Edema Therapeutics Business (2014-2019)
12.7.5 Boehringer Ingelheim Recent Development
12.8 Bausch & Lomb
12.8.1 Bausch & Lomb Company Details
12.8.2 Company Description and Business Overview
12.8.3 Macular Edema Therapeutics Introduction
12.8.4 Bausch & Lomb Revenue in Macular Edema Therapeutics Business (2014-2019)
12.8.5 Bausch & Lomb Recent Development
12.9 Aciont
12.9.1 Aciont Company Details
12.9.2 Company Description and Business Overview
12.9.3 Macular Edema Therapeutics Introduction
12.9.4 Aciont Revenue in Macular Edema Therapeutics Business (2014-2019)
12.9.5 Aciont Recent Development
12.10 ActiveSite Pharmaceuticals
12.10.1 ActiveSite Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Macular Edema Therapeutics Introduction
12.10.4 ActiveSite Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2014-2019)
12.10.5 ActiveSite Pharmaceuticals Recent Development
12.11 Adverum Biotechnologies
12.12 Aerpio Therapeutics
12.13 Ampio Pharmaceuticals
12.14 Araim Pharmaceuticals
12.15 Astellas Pharma

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Macular Edema Therapeutics Key Market Segments
Table Key Players Macular Edema Therapeutics Covered
Table Global Macular Edema Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Macular Edema Therapeutics Market Size Market Share by Type 2014-2025
Figure Laser Treatment Figures
Table Key Players of Laser Treatment
Figure Anti-VEGF Injection Figures
Table Key Players of Anti-VEGF Injection
Figure Anti-Inflammatory Treatment Figures
Table Key Players of Anti-Inflammatory Treatment
Figure Vitrectomy Figures
Table Key Players of Vitrectomy
Table Global Macular Edema Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Cystoid Macular Edema (CME) Case Studies
Figure Diabetic Macular Edema(DME) Case Studies
Figure Macular Edema Therapeutics Report Years Considered
Table Global Macular Edema Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Macular Edema Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Macular Edema Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Macular Edema Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Macular Edema Therapeutics Market Share by Regions 2014-2019
Figure Global Macular Edema Therapeutics Market Share by Regions 2014-2019
Figure Global Macular Edema Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Macular Edema Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Macular Edema Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Macular Edema Therapeutics Market Share by Manufacturers in 2018
Table Global Macular Edema Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Macular Edema Therapeutics Product/Solution/Service
Table Date of Enter into Macular Edema Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Macular Edema Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Macular Edema Therapeutics Market Size Share by Type (2014-2019)
Figure Global Macular Edema Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Macular Edema Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Macular Edema Therapeutics Market Size Share by Application (2014-2019)
Figure Global Macular Edema Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Macular Edema Therapeutics Revenue Market Share by Application in 2018
Figure United States Macular Edema Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Macular Edema Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Macular Edema Therapeutics Market Share (2018-2019)
Table United States Macular Edema Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Macular Edema Therapeutics Market Share by Type (2014-2019)
Table United States Macular Edema Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Macular Edema Therapeutics Market Share by Application (2014-2019)
Figure Europe Macular Edema Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Macular Edema Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Macular Edema Therapeutics Market Share (2018-2019)
Table Europe Macular Edema Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Macular Edema Therapeutics Market Share by Type (2014-2019)
Table Europe Macular Edema Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Macular Edema Therapeutics Market Share by Application (2014-2019)
Figure China Macular Edema Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Macular Edema Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Macular Edema Therapeutics Market Share (2018-2019)
Table China Macular Edema Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Macular Edema Therapeutics Market Share by Type (2014-2019)
Table China Macular Edema Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Macular Edema Therapeutics Market Share by Application (2014-2019)
Figure Japan Macular Edema Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Macular Edema Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Macular Edema Therapeutics Market Share (2018-2019)
Table Japan Macular Edema Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Macular Edema Therapeutics Market Share by Type (2014-2019)
Table Japan Macular Edema Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Macular Edema Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Macular Edema Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Macular Edema Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Macular Edema Therapeutics Market Share (2018-2019)
Table Southeast Asia Macular Edema Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Macular Edema Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Macular Edema Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Macular Edema Therapeutics Market Share by Application (2014-2019)
Figure India Macular Edema Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Macular Edema Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Macular Edema Therapeutics Market Share (2018-2019)
Table India Macular Edema Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Macular Edema Therapeutics Market Share by Type (2014-2019)
Table India Macular Edema Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Macular Edema Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Macular Edema Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Macular Edema Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Macular Edema Therapeutics Market Share (2018-2019)
Table Central & South America Macular Edema Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Macular Edema Therapeutics Market Share by Type (2014-2019)
Table Central & South America Macular Edema Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Macular Edema Therapeutics Market Share by Application (2014-2019)
Table Allergan Company Details
Table Allergan Revenue in Macular Edema Therapeutics Business (2014-2019) (Million US$)
Figure Allergan Revenue Growth Rate in Macular Edema Therapeutics Business (2014-2019)
Table Allergan Recent Development
Table Novartis Company Details
Table Novartis Revenue in Macular Edema Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Macular Edema Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Roche Company Details
Table Roche Revenue in Macular Edema Therapeutics Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Macular Edema Therapeutics Business (2014-2019)
Table Roche Recent Development
Table Regeneron Pharmaceuticals Company Details
Table Regeneron Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2014-2019)(Million US$)
Figure Regeneron Pharmaceuticals Revenue Growth Rate in Macular Edema Therapeutics Business (2014-2019)
Table Regeneron Pharmaceuticals Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Macular Edema Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Macular Edema Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Bayer Company Details
Table Bayer Revenue in Macular Edema Therapeutics Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Macular Edema Therapeutics Business (2014-2019)
Table Bayer Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Macular Edema Therapeutics Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Macular Edema Therapeutics Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Bausch & Lomb Company Details
Table Bausch & Lomb Revenue in Macular Edema Therapeutics Business (2014-2019)(Million US$)
Figure Bausch & Lomb Revenue Growth Rate in Macular Edema Therapeutics Business (2014-2019)
Table Bausch & Lomb Recent Development
Table Aciont Company Details
Table Aciont Revenue in Macular Edema Therapeutics Business (2014-2019)(Million US$)
Figure Aciont Revenue Growth Rate in Macular Edema Therapeutics Business (2014-2019)
Table Aciont Recent Development
Table ActiveSite Pharmaceuticals Company Details
Table ActiveSite Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2014-2019)(Million US$)
Figure ActiveSite Pharmaceuticals Revenue Growth Rate in Macular Edema Therapeutics Business (2014-2019)
Table ActiveSite Pharmaceuticals Recent Development
Table Adverum Biotechnologies Company Details
Table Aerpio Therapeutics Company Details
Table Ampio Pharmaceuticals Company Details
Table Araim Pharmaceuticals Company Details
Table Astellas Pharma Company Details
Table Global Macular Edema Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Macular Edema Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Macular Edema Therapeutics Market Size Share by Regions in 2025
Figure United States Macular Edema Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Macular Edema Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Macular Edema Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Macular Edema Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Macular Edema Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Macular Edema Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Macular Edema Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Macular Edema Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Macular Edema Therapeutics Market Size by Product (2019-2025)
Figure Global Macular Edema Therapeutics Market Size by Product in 2025
Table Global Macular Edema Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Macular Edema Therapeutics Market Size by Application (2019-2025)
Figure Global Macular Edema Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の糖尿病性黄斑浮腫の治療市場：市場規模・現状・予測
    Global Diabetic Macular Edema Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7092 2019年6月14日 95Pages
    当資料は、糖尿病性黄斑浮腫の治療のグローバル市場について調査・分析したレポートで、種類別（レーザー光凝固療法、薬理学療法、ベバシズマブ、ラニビズマブ、トリアムシノロン）、用途別（病院、眼科診療所、研究機関、受託研究機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市...
  • 世界の嚢胞状黄斑浮腫市場：市場規模・現状・予測
    Global Cystoid Macular Edema Market Size, Status and Forecast 2019-2025
    QYR9N7056 2019年6月14日 95Pages
    当資料は、嚢胞状黄斑浮腫のグローバル市場について調査・分析したレポートで、種類別（非ステロイド性抗炎症薬、抗血管内皮細胞増殖因子（VEGF）剤、炭酸アンヒドラーゼ阻害剤、ステロイド）、用途別（病院、外来手術センター、その他、）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米...
  • 世界の黄斑変性症の薬市場：市場規模・現状・予測
    Global Macular Degeneration Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7493 2019年6月14日 97Pages
    当資料は、黄斑変性症の薬のグローバル市場について調査・分析したレポートで、種類別（ルセンティス、アイリーア、アバスチン、スクアラミン、Concecept、その他）、用途別（50〜60歳、60〜70歳、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場...
  • 世界の黄斑変性症の治療市場：市場規模・現状・予測
    Global Macular Degeneration Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7494 2019年6月14日 99Pages
    当資料は、黄斑変性症の治療のグローバル市場について調査・分析したレポートで、種類別（ルセンティス、アイリーア、アバスチン、その他）、用途別（病院、アイクリニック、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています...
  • 世界の肺水腫市場：市場規模・現状・予測
    Global Pulmonary Edema Market Size, Status and Forecast 2019-2025
    QYR9N7908 2019年6月14日 97Pages
    当資料は、肺水腫のグローバル市場について調査・分析したレポートで、種類別（診断、治療）、用途別（病院と診療所、学術機関、小売薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・肺水腫の...
  • 世界の肺水腫の治療市場：市場規模・現状・予測
    Global Pulmonary Edema Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7909 2019年6月14日 97Pages
    当資料は、肺水腫の治療のグローバル市場について調査・分析したレポートで、種類別（診断、治療）、用途別（病院と診療所、学術機関、小売薬局、家庭、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界のデジタル治療薬＆ウェルネス市場：市場規模・現状・予測
    Global Digital Therapeutics & Wellness Market Size, Status and Forecast 2019-2025
    QYR9N7107 2019年6月14日 107Pages
    当資料は、デジタル治療薬＆ウェルネスのグローバル市場について調査・分析したレポートで、種類別（ソフトウェア、デバイス）、用途別（心血管疾患と高血圧、糖尿病と前糖尿病、肥満と減量、禁煙、その他のデジタル治療学）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場...
  • 世界の骨粗鬆症治療薬市場：市場規模・現状・予測
    Global Osteoporosis Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7734 2019年6月14日 94Pages
    当資料は、骨粗鬆症治療薬のグローバル市場について調査・分析したレポートで、種類別（抗吸収薬、同化薬）、用途別（男性、女性）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・骨粗鬆症治療薬の...
  • 世界の脂質異常症治療薬市場：市場規模・現状・予測
    Global Dyslipidemia Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7136 2019年6月14日 93Pages
    当資料は、脂質異常症治療薬のグローバル市場について調査・分析したレポートで、種類別（スタチン、非スタチン、組み合わせ薬）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。<...
  • 世界の過活動膀胱治療学市場：市場規模・現状・予測
    Global Overactive Bladder Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7750 2019年6月14日 92Pages
    当資料は、過活動膀胱治療学のグローバル市場について調査・分析したレポートで、種類別（抗コリン作用薬、ミラベグロン、ボトックス）、用途別（特発性過活動膀胱、神経性過活動膀胱）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれていま...
  • 世界の糖尿病性黄斑浮腫の治療市場：市場規模・現状・予測世界の糖尿病性黄斑浮腫の治療市場：市場規模・現状・予測 Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may cause by leakage of plasma constituents into the surrounding, consequently leading to edema.Increasing prevalence of diabetes in the prime factor driving g…
  • 世界の嚢胞状黄斑浮腫市場：市場規模・現状・予測世界の嚢胞状黄斑浮腫市場：市場規模・現状・予測 Cystoid macular edema (CME) also known as Irvine Gass Syndrome is a painless disorder affecting the central retina or macula. This condition is characterized by multiple cysts like areas of fluid in the macula causing retinal swelling or edema. CME is the retinal thickening of macula due to disrupti…
  • 世界の黄斑変性症の治療市場：市場規模・現状・予測世界の黄斑変性症の治療市場：市場規模・現状・予測 Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in blurred or no vision in the center of the visual field. Early on there are often no symptoms. Over time, however, some people experience a gradual worsening of vision that m…
  • 世界の肺水腫の治療市場：市場規模・現状・予測世界の肺水腫の治療市場：市場規模・現状・予測 Pulmonary edema refers to the generation and reflux imbalance of tissue fluid in the lung caused by some reasons, so that a large number of tissue fluid in a very short period of time can not be absorbed by the pulmonary lymphatic and pulmonary vein system, from the pulmonary capillary osmosis, accu…
  • 世界の黄斑変性症の薬市場：市場規模・現状・予測世界の黄斑変性症の薬市場：市場規模・現状・予測 Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above.The North American region is the most lucrative market, owi…